Boehringer Ingelheim International GmbH
The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and positions for Boehringer Ingelheim International GmbH in this year’s pharmaceutical sales data alongside recent articles on PMLiVE featuring Boehringer Ingelheim International GmbH.
Recent articles on PMLiVE featuring Boehringer Ingelheim International GmbH
He will also join the company’s board ofmanaging directors
Follows Teva’s $40.5bn purchase of Allgeran’s generics business earlier this week
Say revisions to the alliance will not affect the world’s largest markets
Data provided by GlobalData
GlobalData provides trusted intelligence on the world’s largest industries including Pharmaceutical and Medical Devices. With over 2,000 in-house experts, our data-driven, technology-powered approach delivers gold-standard insights to help businesses navigate complex markets and predict future trends.
Our integrated platform empowers 4,000 of the world’s largest companies—including over 70% of FTSE 100 and 60% of Fortune 100 firms—to make timely, informed decisions through unique data, expert analysis, and innovative consulting solutions.
To find out more about how our research and insights can help you, please visit https://www.globaldata.com/who-we-are/why-globaldata/
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE’s Top Pharma List – Methodology